Healthcare provider profile · identity verified

Gena L Napier, M.D.

Family Practice · SAINT LOUIS, MO · NPI 1073654091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	707	219
Amlodipine Besylate	Amlodipine Besylate	657	193
Tramadol Hcl	Tramadol Hcl	381	90
Lisinopril	Lisinopril	374	107
Levothyroxine Sodium	Levothyroxine Sodium	346	86
Losartan Potassium	Losartan Potassium	314	99
Alprazolam	Alprazolam	286	62
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	250	44
Albuterol Sulfate Hfa	Albuterol Sulfate	235	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	235	69
Furosemide	Furosemide	223	69
Hydrochlorothiazide	Hydrochlorothiazide	216	63
Rosuvastatin Calcium	Rosuvastatin Calcium	212	64
Metformin Hcl	Metformin Hcl	205	64
Metoprolol Succinate	Metoprolol Succinate	203	56
Gabapentin	Gabapentin	195	73
Zolpidem Tartrate	Zolpidem Tartrate	181	38
Fluticasone Propionate	Fluticasone Propionate	177	66
Famotidine	Famotidine	174	62
Pantoprazole Sodium	Pantoprazole Sodium	172	50
Omeprazole	Omeprazole	170	54
Vitamin D2	Ergocalciferol (Vitamin D2)	159	51
Pregabalin	Pregabalin	139	28
Metoprolol Tartrate	Metoprolol Tartrate	136	41
Carvedilol	Carvedilol	131	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	130	66
Simvastatin	Simvastatin	124	30
Eliquis	Apixaban	121	29
Triamcinolone Acetonide	Triamcinolone Acetonide	109	55
Duloxetine Hcl	Duloxetine Hcl	103	39
Metformin Hcl Er	Metformin Hcl	103	31
Diclofenac Sodium	Diclofenac Sodium	95	48
Allopurinol	Allopurinol	94	28
Chlorthalidone	Chlorthalidone	91	30
Ozempic	Semaglutide	90	21
Montelukast Sodium	Montelukast Sodium	85	27
Trazodone Hcl	Trazodone Hcl	84	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	83	34
Prednisone	Prednisone	83	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	20
Potassium Chloride	Potassium Chloride	76	24
Alendronate Sodium	Alendronate Sodium	71	18
Spironolactone	Spironolactone	70	23
Glipizide	Glipizide	69	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	22
Tamsulosin Hcl	Tamsulosin Hcl	67	19
Bupropion Xl	Bupropion Hcl	65	16
Clonazepam	Clonazepam	65	12
Clopidogrel	Clopidogrel Bisulfate	65	20
Pravastatin Sodium	Pravastatin Sodium	62	20
Arexvy	Rsvpref3 Antigen/As01e/Pf	61	61
Baclofen	Baclofen	60	24
Diazepam	Diazepam	60	20
Atenolol	Atenolol	59	16
Meloxicam	Meloxicam	59	17
Lovastatin	Lovastatin	58	16
Sertraline Hcl	Sertraline Hcl	58	21
Fluoxetine Hcl	Fluoxetine Hcl	57	16
Lorazepam	Lorazepam	57	18
Jardiance	Empagliflozin	55	19
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Hydralazine Hcl	Hydralazine Hcl	53	16
Hydroxyzine Hcl	Hydroxyzine Hcl	51	20
Olmesartan Medoxomil	Olmesartan Medoxomil	50	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	16
Ibuprofen	Ibuprofen	48	19
Farxiga	Dapagliflozin Propanediol	45	12
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	34
Acetaminophen-Codeine	Acetaminophen With Codeine	43	15
Celecoxib	Celecoxib	41	15
Citalopram Hbr	Citalopram Hydrobromide	41	12
Nifedipine Er	Nifedipine	40	12
Xarelto	Rivaroxaban	40	13
Nebivolol Hcl	Nebivolol Hcl	39	suppressed
Klor-Con M20	Potassium Chloride	38	12
Zolpidem Tartrate Er	Zolpidem Tartrate	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	11
Clotrimazole	Clotrimazole	37	21
Ipratropium Bromide	Ipratropium Bromide	37	15
Myrbetriq	Mirabegron	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Mirtazapine	Mirtazapine	34	11
Mounjaro	Tirzepatide	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	15
Warfarin Sodium	Warfarin Sodium	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Hydrocortisone	Hydrocortisone	32	17
Naproxen	Naproxen	32	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	suppressed
Azelastine Hcl	Azelastine Hcl	31	12
Donepezil Hcl	Donepezil Hcl	30	12
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Doxepin Hcl	Doxepin Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	17
Belsomra	Suvorexant	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Cephalexin	Cephalexin	26	17
Lactulose	Lactulose	26	13
Linzess	Linaclotide	26	11
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Indapamide	Indapamide	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Fluconazole	Fluconazole	24	17
Naloxone Hcl	Naloxone Hcl	24	24
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Azithromycin	Azithromycin	22	21
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Finasteride	Finasteride	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Topiramate	Topiramate	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Irbesartan	Irbesartan	17	suppressed
Nystatin	Nystatin	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Lacosamide	Lacosamide	16	suppressed
Temazepam	Temazepam	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Valsartan	Valsartan	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Insulin Aspart	Insulin Aspart	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Ramipril	Ramipril	13	suppressed
Testosterone	Testosterone	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error